ABX196

Drug identity checked against registry records

Also recorded as Obefazimod

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ABX196 in Combination With Nivolumab in Patients With Hepatocellular CarcinomaNCT03897543ABVXPhase 1, Phase 2Completed2022-04-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.